# Pharmacoequity in Anticoagulation Among Medicare Patients With Venous Thromboembolism

**Authors:** Amina A. Alkhalaf, Sungho Bea, Geetha S. Iyer, Julie C. Lauffenburger, Katsiaryna Bykov

PMC · DOI: 10.1001/jamanetworkopen.2025.44529 · JAMA Network Open · 2025-11-20

## TL;DR

The study examines how race and ethnicity affect whether Medicare patients with blood clots receive recommended anticoagulant treatments.

## Contribution

The study provides new evidence on racial and ethnic disparities in anticoagulant prescribing among Medicare patients with venous thromboembolism.

## Key findings

- Race and ethnicity are associated with the likelihood of receiving guideline-recommended direct oral anticoagulants.
- Disparities persist even after adjusting for clinical and socioeconomic factors.

## Abstract

This cohort study investigates the association of race and ethnicity with initiation of guideline-recommended direct oral anticoagulants in Medicare beneficiaries with venous thromboembolism.

## Linked entities

- **Diseases:** venous thromboembolism (MONDO:0005399)

## Full-text entities

- **Diseases:** Venous Thromboembolism (MESH:D054556)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12635871/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12635871/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12635871/full.md

---
Source: https://tomesphere.com/paper/PMC12635871